About Us

The MICROBRADAM Consortium was started in 2015 and is involved in the development of innovatve MR methods.

Social Media

MSCA RISE FundsThe Research Executive Agency has released a flyer about Marie Skłodowska-Curie Actions Staff Exchanges in Horizon Europe Framework, Check it here. Other info on MSCA-RISE on the REA website 


The Results in Brief report has been published on the CORDIS portal.

The project H2020 MSCA-RISE 691110 MICROBRADAM developed innovative MRI technologies to investigate neurological diseases. Among the most striking features of the project was the involvement of young researchers from EU countries, which had the opportunity of travelling to different laboratories involved in the project during secondments that lasted 4-12 months.

The project H2020 MSCA-RISE 691110 MICROBRADAM is now ending. During its 4-years activities, the Consortium has developed innovative MRI technologies to investigate neurological diseases, and has improved knowledge sharing between leading EU and US institutions.

Human brain rendering

The MICROBRADAM collaboration between scientists in Europe and US, thanks to the grant awarded as a part of the Marie Skłodowska-Curie actions under Horizon 2020, has developed a multimodal approach for the early diagnosys of Parkinson's Disease based on MRI images.

"We still lack an effective treatment for Parkinson's Disease, however our new approach has the potential to identify the early damages to tissue caused by pathology, thus helping an earlier diagnosys and - in perspective -  the assessment of new treatments", declared Federico Giove, coordinator of the European project.

The MICROBRADAM partnership includes institution and scientists from Finland, Czech Republic, Italy and USA, and aims to transfer the newly developed technologies to the clinical practice.

AD semantic figure